Nature's Sunshine Products Total Assets 2012-2026 | NATR

Nature's Sunshine Products total assets from 2012 to 2026. Total assets can be defined as the sum of all assets on a company's balance sheet.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Nature's Sunshine Products Annual Total Assets
(Millions of US $)
2025 $261
2024 $241
2023 $250
2022 $230
2021 $259
2020 $249
2019 $213
2018 $193
2017 $195
2016 $206
2015 $201
2014 $197
2013 $200
2012 $194
2011 $176
Nature's Sunshine Products Quarterly Total Assets
(Millions of US $)
2026-06-30 $260
2026-03-31 $261
2025-12-31 $261
2025-09-30 $265
2025-06-30 $255
2025-03-31 $253
2024-12-31 $241
2024-09-30 $245
2024-06-30 $236
2024-03-31 $247
2023-12-31 $250
2023-09-30 $240
2023-06-30 $236
2023-03-31 $235
2022-12-31 $230
2022-09-30 $224
2022-06-30 $233
2022-03-31 $239
2021-12-31 $259
2021-09-30 $240
2021-06-30 $233
2021-03-31 $246
2020-12-31 $249
2020-09-30 $237
2020-06-30 $227
2020-03-31 $215
2019-12-31 $213
2019-09-30 $215
2019-06-30 $216
2019-03-31 $209
2018-12-31 $193
2018-09-30 $192
2018-06-30 $194
2018-03-31 $192
2017-12-31 $195
2017-09-30 $222
2017-06-30 $209
2017-03-31 $211
2016-12-31 $206
2016-09-30 $215
2016-06-30 $211
2016-03-31 $210
2015-12-31 $201
2015-09-30 $197
2015-06-30 $199
2015-03-31 $198
2014-12-31 $197
2014-09-30 $209
2014-06-30 $205
2014-03-31 $204
2013-12-31 $200
2013-09-30 $195
2013-06-30 $200
2013-03-31 $196
2012-12-31 $194
2012-09-30 $193
2012-06-30 $183
2012-03-31 $178
2011-12-31 $176
2011-09-30 $175
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.230B $0.480B
Nature's Sunshine Products manufactures and markets through direct sales encapsulated and tableted herbal products, high quality natural vitamins, and other complementary products. In addition to the United States, the Company has operations in Japan, Mexico, Central America, South Korea, Canada, Dominican Republic, Venezuela, Ecuador, Peru, the United Kingdom, Columbia, Brazil, Thailand, Israel, Singapore, Malaysia, Indonesia, the Philippines, Australia, Hong Kong, Taiwan, Russia, Ukraine, Latvia, Lithuania, Kazakhstan, Mongolia, Belarus, China, Poland, Germany, Austria, Norway, Sweden, the Czech Republic and the Netherlands. The Company also has exclusive distribution agreements with selected companies in Argentina, Australia, Chile, New Zealand, and Norway.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $67.606B 22.33
Takeda Pharmaceutical (TAK) Japan $59.727B 11.10
UCB SA (UCBJY) Belgium $44.643B 0.00
BeOne Medicines - (ONC) Switzerland $38.215B 61.28
Otsuka Holdings, - (OTSKY) Japan $37.468B 14.01
Sandoz Group AG (SDZNY) Switzerland $35.090B 0.00
Daiichi Sankyo, - (DSNKY) Japan $33.774B 21.08
Zoetis (ZTS) United States $30.165B 11.09
Astellas Pharma (ALPMY) Japan $26.725B 8.84
United Therapeutics (UTHR) United States $21.380B 17.83
Merck (MKKGY) Germany $19.470B 15.53
Shionogi (SGIOY) Japan $15.760B 9.26
IPSEN (IPSEY) France $15.498B 0.00
Neurocrine Biosciences (NBIX) United States $15.197B 20.65
Summit Therapeutics (SMMT) United States $13.801B 0.00
Orion OYJ (ORINY) Finland $12.984B 18.93
Madrigal Pharmaceuticals (MDGL) United States $12.224B 0.00
Corcept Therapeutics (CORT) United States $12.086B 266.21
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.965B 15.26
Eisai (ESAIY) $9.088B 0.00
Crinetics Pharmaceuticals (CRNX) United States $9.013B 0.00
Ionis Pharmaceuticals (IONS) United States $7.452B 0.00
Ono Pharmaceutical (OPHLF) Japan $7.049B 13.27
Stevanato Group S.p.A (STVN) Italy $6.823B 34.14
Centessa Pharmaceuticals (CNTA) United Kingdom $6.267B 0.00
Oruka Therapeutics (ORKA) United States $6.194B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $5.774B 21.02
Definium Therapeutics (DFTX) United States $5.086B 0.00
Grifols, S.A (GRFS) Spain $5.036B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.923B 0.00
Relay Therapeutics (RLAY) United States $4.129B 0.00
Indivior Pharmaceuticals (INDV) United States $4.054B 9.41
Catalyst Pharmaceuticals (CPRX) United States $3.855B 11.93
Amylyx Pharmaceuticals (AMLX) United States $3.636B 0.00
Enliven Therapeutics (ELVN) United States $3.599B 0.00
Dyne Therapeutics (DYN) United States $3.232B 0.00
Hypermarcas (HYPMY) Brazil $3.196B 9.08
Soleno Therapeutics (SLNO) United States $2.717B 228.83
NewAmsterdam Pharma (NAMS) Netherlands $2.532B 0.00
Guardian Pharmacy Services (GRDN) United States $2.317B 43.89
Nektar Therapeutics (NKTR) United States $2.301B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.257B 16.63
Ocular Therapeutix (OCUL) United States $2.168B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.154B 5.81
Avadel Pharmaceuticals (AVDL) Ireland $2.113B 0.00
Xencor (XNCR) United States $1.763B 0.00
KARDIGAN INC (KARD) United States $1.619B 0.00
Xeris Biopharma Holdings (XERS) United States $1.418B 111.14
Harrow (HROW) United States $1.282B 0.00
Aktis Oncology (AKTS) United States $1.221B 0.00
Cronos Group (CRON) Canada $1.213B 29.91
Seaport Therapeutics (SPTX) United States $1.185B 0.00
Bioventus (BVS) United States $1.110B 17.37
Savara (SVRA) United States $1.054B 0.00
Cybin (HELP) Canada $1.018B 0.00
KalVista Pharmaceuticals (KALV) United States $0.993B 0.00
Avalo Therapeutics (AVTX) United States $0.889B 0.00
Theravance Biopharma (TBPH) United States $0.884B 0.00
Ardelyx (ARDX) United States $0.845B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.823B 11.35
Esperion Therapeutics (ESPR) United States $0.819B 0.00
Achieve Life Sciences (ACHV) Canada $0.764B 0.00
4D Molecular Therapeutics (FDMT) United States $0.760B 0.00
Apnimed (APMD) $0.754B 0.00
Silence Therapeutics (SLN) United Kingdom $0.753B 0.00
Aclaris Therapeutics (ACRS) United States $0.744B 0.00
Collegium Pharmaceutical (COLL) United States $0.722B 3.18
Zevra Therapeutics (ZVRA) United States $0.701B 7.47
Ironwood Pharmaceuticals (IRWD) United States $0.689B 5.35
Altimmune (ALT) United States $0.630B 0.00
OmniAb (OABI) United States $0.630B 0.00
Aquestive Therapeutics (AQST) United States $0.605B 0.00
Evotec AG (EVO) Germany $0.580B 0.00
ProKidney (PROK) United States $0.559B 0.00
Relmada Therapeutics (RLMD) United States $0.450B 0.00
Indaptus Therapeutics (INDP) United States $0.428B 0.00
ARS Pharmaceuticals (SPRY) United States $0.414B 0.00
Larimar Therapeutics (LRMR) United States $0.408B 0.00
Prelude Therapeutics (PRLD) United States $0.357B 0.00
Lexeo Therapeutics (LXEO) United States $0.341B 0.00
Century Therapeutics (IPSC) United States $0.337B 0.00
Inhibikase Therapeutics (IKT) United States $0.322B 0.00
Avita Medical (RCEL) United States $0.322B 0.00
Pyxis Oncology (PYXS) United States $0.279B 0.00
USANA Health Sciences (USNA) United States $0.272B 14.86
Lyell Immunopharma (LYEL) United States $0.264B 0.00
Elite Pharmaceuticals (ELTP) United States $0.264B 12.25
Akebia Therapeutics (AKBA) United States $0.254B 0.00
Galectin Therapeutics (GALT) United States $0.242B 0.00
Siga Technologies (SIGA) United States $0.223B 0.00
Cardiol Therapeutics (CRDL) Canada $0.221B 0.00
Protara Therapeutics (TARA) United States $0.214B 0.00
Profound Medical (PROF) Canada $0.213B 0.00
AleAnna (ANNA) United States $0.210B 16.58
Journey Medical (DERM) United States $0.206B 0.00
Korro Bio (KRRO) United States $0.204B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.202B 0.00
Surrozen (SRZN) United States $0.197B 0.00
Organogenesis (ORGO) United States $0.179B 0.00
MediWound (MDWD) Israel $0.170B 0.00
Minerva Neurosciences (NERV) United States $0.166B 0.00
Atrium Therapeutics (RNA) United States $0.163B 0.00
NRx Pharmaceuticals (NRXP) United States $0.145B 0.00
Innate Pharma SA (IPHYF) France $0.138B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.136B 0.00
Unicycive Therapeutics (UNCY) United States $0.133B 0.00
Assertio Holdings (ASRT) United States $0.116B 0.00
VAXART, INC (VXRT) United States $0.115B 2.96
Vivani Medical (VANI) United States $0.110B 0.00
Rafael Holdings (RFL) United States $0.107B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.105B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.103B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
PolyPid (PYPD) Israel $0.099B 0.00
ElectroCore (ECOR) United States $0.096B 0.00
HST Global (HSTC) United States $0.092B 0.00
Fractyl Health (GUTS) United States $0.090B 0.00
Nutriband (NTRB) United States $0.086B 0.00
Aldeyra Therapeutics (ALDX) United States $0.083B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.078B 0.00
Telomir Pharmaceuticals (TELO) United States $0.078B 0.00
PMV Pharmaceuticals (PMVP) United States $0.076B 0.00
Gain Therapeutics (GANX) United States $0.075B 0.00
Acrivon Therapeutics (ACRV) United States $0.073B 0.00
Champions Oncology (CSBR) United States $0.069B 0.00
Talphera (TLPH) United States $0.062B 0.00
Nuo Therapeutics (AURX) $0.061B 0.00
Heron Therapeutics (HRTX) United States $0.060B 0.00
Dominari Holdings (DOMH) United States $0.052B 0.00
Veraxa Biotech AG (VRXA) United States $0.048B 0.00
Incannex Healthcare (IXHL) Australia $0.045B 0.00
SCYNEXIS (SCYX) United States $0.041B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Karyopharm Therapeutics (KPTI) United States $0.039B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Context Therapeutics (CNTX) United States $0.035B 0.00
Lite Strategy (LITS) United States $0.035B 0.00
TransCode Therapeutics (RNAZ) United States $0.028B 0.00
Optimi Health (OPTH) Canada $0.028B 0.00
Cosmos Health (COSM) United States $0.028B 0.00
Plus Therapeutics (PSTV) United States $0.027B 0.00
TherapeuticsMD (TXMD) United States $0.025B 0.00
Universe Pharmaceuticals INC (UPC) China $0.024B 0.00
Tempest Therapeutics (TPST) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Klotho Neurosciences (KLTO) United States $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.015B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.015B 0.00
BioVie (BIVI) United States $0.015B 0.00
Enlivex (ENLV) Israel $0.014B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.014B 0.00
Vyome Holdings (HIND) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Natural Alternatives (NAII) United States $0.012B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
CASI Pharmaceuticals (CASI) China $0.010B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Wellgistics Health (WGRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Inotiv (NOTV) United States $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.007B 0.00
Ernexa Therapeutics (ERNA) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.005B 0.00
Liminatus Pharma (LIMN) United States $0.004B 0.00
Nuvilex (PMCB) United States $0.004B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Addex Therapeutics (ADXN) Switzerland $0.004B 0.00
Niki BioSolutions (NIKI) United Kingdom $0.004B 0.00
Galmed Pharmaceuticals (EOCN) Israel $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Jupiter Neurosciences (JUNS) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Vivos Therapeutics (VVOS) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
Clearmind Medicine (CMND) Canada $0.001B 0.00
CDT Equity (CDT) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00